申请人:The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
公开号:US10238639B2
公开(公告)日:2019-03-26
Selective azophenol inhibitors of a wild type or an altered ERG protein expression are described, where the inhibitors represent a compound of Formula (I) or Formula (II)
wherein X, X1, X2, X3, X4 and X5, R1 through R4 and R9 are as described.
描述了野生型或改变的 ERG 蛋白表达的选择性偶氮苯酚抑制剂,其中抑制剂代表式 (I) 或式 (II) 的化合物
其中 X、X1、X2、X3、X4 和 X5、R1 至 R4 和 R9 如所述。